MRK
Merck & Co., Inc.
Stock
$148.69−0.09 (−0.06%)Close Sep 28, 2026
MRK's free cash flow for 2025 was $12.36 billion, down 31.7% from the year before.
From SEC filings, Latest filing: 10-Q, Aug 7, 2026
| Free cash flow (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $16.06B | +9.1% | 16.2% | 0.9% |
| Free cash flow (TTM) | $16.06B |
|---|---|
| YoY | +9.1% |
| 5-year CAGR | 16.2% |
| 10-year CAGR | 0.9% |
Free cash flow
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $12.4B | −31.7% |
| 2024 | $18.1B | +97.9% |
| 2023 | $9.1B | −37.8% |
| 2022 | $14.7B | — |
| 2020 | $5.8B | −42.2% |
| 2019 | $10.1B | +21.2% |
| 2018 | $8.3B | +82.1% |
| 2017 | $4.6B | −47.9% |
| 2016 | $8.8B | −22.2% |
| 2015 | $11.3B | +68.7% |
| 2014 | $6.7B | −34.0% |
| 2013 | $10.1B | +25.3% |
| 2012 | $8.1B | −24.3% |
| 2011 | $10.7B | +16.6% |
| 2010 | $9.1B | +373.5% |
| 2009 | $1.9B | −63.4% |
| 2008 | $5.3B | −11.9% |
| 2007 | $6.0B | — |